DC Chemicals · Product datasheet

BI-2865 — Datasheet

CAT. NO. DC65502

Product page and current package options

ParameterValue
Chemical NameBI-2865
CAS No.2937327-93-8
SynonymsBI 2865, BI2865
FormulaC23H27N7O2S
M.Wt465.571182489395
SMILESC12CCC[C@](C)(C3ON=C(C4=NC=CC(O[C@H]([C@@H]5CCCN5C)C)=N4)N=3)C=1C(C#N)=C(N)S2
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

BI-2865 is a none-covalent pan-KRAS Inhibitor. BI-2865 blocked nucleotide exchange to prevent the activation of wild-type KRAS and a broad range of KRAS mutants, including G12A/C/D/F/V/S, G13C/D, V14I, L19F, Q22K, D33E, Q61H, K117N and A146V/T. Inhibition of downstream signalling and proliferation was restricted to cancer cells harbouring mutant KRAS, and drug treatment suppressed KRAS mutant tumour growth in mice, without having a detrimental effect on animal weight.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

[1]. Kim D, et al. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature. 2023 May 31

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation